Gefitinib-Induced Interstitial Lung Disease in Korean Lung Cancer Patients

PURPOSE: Interstitial lung disease (ILD) is a serious adverse effect of gefitinib. We examined the incidence and clinical characteristics of drug-induced ILD in Korean non-small cell lung carcinoma patients treated with gefitinib. MATERIALS AND METHODS: A retrospective cohort study was performed in...

Descripción completa

Detalles Bibliográficos
Autores principales: Beom, Seung-Hoon, Kim, Dong-Wan, Sim, Sung Hoon, Keam, Bhumsuk, Park, Jin Hyun, Lee, Jeong-Ok, Kim, Tae Min, Lee, Se-Hoon, Heo, Dae Seog
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4720097/
https://www.ncbi.nlm.nih.gov/pubmed/25761482
http://dx.doi.org/10.4143/crt.2014.201

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4720097/
https://www.ncbi.nlm.nih.gov/pubmed/25761482
http://dx.doi.org/10.4143/crt.2014.201

Ejemplares similares